Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.

NCT04860687 is registered in ClinicalTrials.gov with Azienda Sanitaria-Universitaria Integrata di Udine as lead sponsor.

NCT NCT04860687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04860687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.
Lead sponsor
Azienda Sanitaria-Universitaria Integrata di Udine
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2021
Completion date
December 31, 2021
Enrollment
309 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, post traumatic stress disorder, quality of life